Strategic agreements

More than 25 international agreements.

The Bagó Group is renowned for its unshakeable commitment to quality, the continuous therapeutic innovation of its products, the constant investment in R&D, the thrust, dynamics and effort of all the professionals working in the Group, and its competitive industrial structure.

The synergy of these factors together with the transparency of Bagó´s policy with respect to Intellectual Property Rights, have helped Bagó turn into a regional role model and strategic partner for the most important pharmaceutical companies worldwide.

The strength of our leadership is shown by more than 25 in-licence products, and by a state-of-the-art line of products.

At present, the Bagó Group holds strategic commercial agreements and joint ventures with top class companies such as: Astellas, Astra Zeneca, Boehringer Ingelheim, Ferrer, Ferozsons, Fidia, Gedeon Richter, IBSA, MSD, Novartis, Pfizer, Synthon, UCB and United therapeutics, among others.